These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 21601378)

  • 21. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience.
    Vitucci C; Tirelli C; Graziano F; Santoro E
    J Surg Oncol; 2000 Jun; 74(2):108-15. PubMed ID: 10914819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early ipsilateral breast tumor recurrences after breast conservation affect survival: an analysis of the National Cancer Institute randomized trial.
    Brooks JP; Danforth DN; Albert P; Sciuto LC; Smith SL; Camphausen KA; Poggi MM
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):785-9. PubMed ID: 15936560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital.
    Dinshaw KA; Sarin R; Budrukkar AN; Shrivastava SK; Deshpande DD; Chinoy RF; Badwe R; Hawaldar R
    J Surg Oncol; 2006 Aug; 94(2):105-13. PubMed ID: 16847919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.
    Levy A; Borget I; Bahri M; Arnedos M; Rivin E; Vielh P; Balleyguier C; Rimareix F; Bourgier C
    Breast J; 2014; 20(4):381-7. PubMed ID: 24890310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer.
    Parviz M; Cassel JB; Kaplan BJ; Karp SE; Neifeld JP; Penberthy LT; Bear HD
    J Surg Oncol; 2003 Oct; 84(2):57-62. PubMed ID: 14502777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term results with breast-conserving therapy for patients with early stage breast carcinoma in a community hospital setting.
    Kini VR; White JR; Horwitz EM; Dmuchowski CF; Martinez AA; Vicini FA
    Cancer; 1998 Jan; 82(1):127-33. PubMed ID: 9428488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer.
    Almahariq MF; Quinn TJ; Siddiqui Z; Jawad MS; Chen PY; Gustafson GS; Dilworth JT
    Radiother Oncol; 2020 Jan; 142():186-194. PubMed ID: 31615634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients.
    van Laar C; van der Sangen MJ; Poortmans PM; Nieuwenhuijzen GA; Roukema JA; Roumen RM; Tjan-Heijnen VC; Voogd AC
    Eur J Cancer; 2013 Oct; 49(15):3093-101. PubMed ID: 23800672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes after breast conservation therapy for early stage breast cancer in a community setting.
    McCloskey SA; Botnick LE; Rose CM; Malcolm AW; Ozohan ML; Mena R; Llamas L; Tao ML
    Breast J; 2006; 12(2):138-44. PubMed ID: 16509838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer.
    Agarwal S; Pappas L; Neumayer L; Kokeny K; Agarwal J
    JAMA Surg; 2014 Mar; 149(3):267-74. PubMed ID: 24429935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up.
    Kunkler IH; Kerr GR; Thomas JS; Jack WJ; Bartlett JM; Pedersen HC; Cameron DA; Dixon JM; Chetty U;
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):829-38. PubMed ID: 22197227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma.
    Lukens JN; Vapiwala N; Hwang WT; Solin LJ
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1475-81. PubMed ID: 19004570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
    Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
    Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study.
    Frandsen J; Ly D; Cannon G; Suneja G; Matsen C; Gaffney DK; Wright M; Kokeny KE; Poppe MM
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1096-103. PubMed ID: 26581146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
    Fodor J; Polgár C; Major T; Németh G
    Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does lymphovascular invasion predict regional nodal failure in breast cancer patients with zero to three positive lymph nodes treated with conserving surgery and radiotherapy? Implications for regional radiation.
    Boutrus R; Abi-Raad R; Niemierko A; Brachtel EF; Rizk L; Kelada A; Taghian AG
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):793-8. PubMed ID: 20171799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.